N
NanoHive Medical
A pioneer and innovator in 3D-printed spinal interbody implants and instruments
About NanoHive Medical
NanoHive Medical, LLC operates within the spinal interbody fusion device market, estimated at over $1.9 billion, by providing 3D-printed titanium implants. The company, founded as HD LifeSciences in 2014 by Ian Helmar, is headquartered in Woburn, Massachusetts. Helmar, the company's Founder and Chief Technology Officer, leveraged his mechanical engineering background from Rensselaer Polytechnic Institute and over a decade of experience in the spine market to develop the company's core technology.
The business centers on the design, manufacturing, and sale of spinal fusion devices to surgeons and healthcare facilities. Its revenue model is based on the sale of these medical devices through direct sales and strategic distribution partnerships. A key milestone was the company's rebranding from HD LifeSciences to NanoHive Medical in September 2021, a move intended to better reflect its unique technology platform. This coincided with the appointment of a new executive team, including President and CEO Patrick O'Donnell, a veteran with over 30 years in the medical device and orthobiologics sectors. The company has secured multiple rounds of funding, including a $7 million Series C in August 2024, to expand its commercial operations, product lines, and enter international markets.
NanoHive Medical's core product is the Hive™ portfolio of interbody fusion devices, which utilizes a proprietary Soft Titanium® technology. This technology employs additive manufacturing to create a biomimetic lattice structure that mimics the properties of cancellous bone. The implants are over 70% porous, designed to encourage bony ingrowth and ongrowth. A key feature is the rhombic dodecahedron lattice structure, which provides a stiffness comparable to PEEK materials while maintaining the strength of bone, potentially reducing implant subsidence. The design also results in a low-density structure, which improves visibility in CT and MRI scans. The portfolio includes a variety of implants for different surgical approaches, such as the Hive™ Standalone Cervical, Anterior Lumbar (ALIF), and Posterior Lumbar (PLIF) systems. These devices have received multiple 510(k) clearances from the U.S. Food and Drug Administration (FDA) and are indicated for conditions like Degenerative Disc Disease (DDD).
Source: Dealroom company dataNews
Open roles
NanoHive Medical in the Woburn ecosystem
The NanoHive Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about NanoHive Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See NanoHive Medical on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


